91 related articles for article (PubMed ID: 1589701)
21. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Lijnen P; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
[TBL] [Abstract][Full Text] [Related]
22. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
23. Pressure and humoral changes induced by atenolol and hydrochlorothiazide + amiloride, alone and in free combination. A comparative between-patient study.
Salvadeo A; Villa G; Segagni S; Piazza V; Galli F
Int J Clin Pharmacol Res; 1983; 3(5):371-7. PubMed ID: 6678831
[TBL] [Abstract][Full Text] [Related]
24. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
Houston MC; Olafsson L; Burger MC
Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
[TBL] [Abstract][Full Text] [Related]
25. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
Talseth T; Westlie L; Daae L
J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic findings and response rates to beta-blocker--and diuretic monotherapy in mild and moderate hypertension. A one year randomized, double blind study in 100 men.
Otterstad JE; Erikssen J; Froeland G; Soeyland AK; Saltvedt E
Blood Press; 1992 Dec; 1(4):212-8. PubMed ID: 1345218
[TBL] [Abstract][Full Text] [Related]
28. The results of a large multicentre study comparing low-dose lisinopril-hydrochlorothiazide with the monocomponents.
Lang H
J Hum Hypertens; 1991 Dec; 5 Suppl 2():73-6. PubMed ID: 1665182
[TBL] [Abstract][Full Text] [Related]
29. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
[TBL] [Abstract][Full Text] [Related]
30. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
Jørgensen F; Bredesgaard P; Johansen P
Pharmatherapeutica; 1986; 4(10):655-64. PubMed ID: 3602017
[TBL] [Abstract][Full Text] [Related]
31. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
32. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
[TBL] [Abstract][Full Text] [Related]
33. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Lakshman MR; Reda DJ; Materson BJ; Cushman WC; Freis ED
Arch Intern Med; 1999 Mar; 159(6):551-8. PubMed ID: 10090111
[TBL] [Abstract][Full Text] [Related]
34. Changes in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year's treatment with atenolol vs. hydrochlorothiazide and amiloride (Moduretic): a double-blind, randomized study.
Otterstad JE; Froeland G; Wasenius Soeyland AK; Knutsen KM; Ekeli T
J Intern Med; 1992 May; 231(5):493-501. PubMed ID: 1534831
[TBL] [Abstract][Full Text] [Related]
35. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
[TBL] [Abstract][Full Text] [Related]
36. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
[TBL] [Abstract][Full Text] [Related]
37. Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.
Superko HR; Wood PD; Krauss RM
Am J Med; 1989 Jan; 86(1B):26-31. PubMed ID: 2913769
[TBL] [Abstract][Full Text] [Related]
38. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456
[TBL] [Abstract][Full Text] [Related]
39. A double-blind comparison of perindopril and hydrochlorothiazide-amiloride in mild to moderate essential hypertension.
Andrejak M; Santoni JP; Carré A; Deruyttere M; Magometschnigg D; Gotzen R; Stumpe KO
Fundam Clin Pharmacol; 1991; 5(3):185-92. PubMed ID: 1682228
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.
Välimäki M; Maass L; Harno K; Nikkilä EA
Eur J Clin Pharmacol; 1986; 30(1):17-20. PubMed ID: 3709628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
